SEC Form 4/A · accession 0001209191-15-009970
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jason Ryan
Officer — Senior Vice President, Finance
Period of report
Jun 5, 2014
Accepted (ET)
Feb 5, 2015 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2014 | M | 4,773 | $0.08 | A | 4,773 | D | |
| Common StockF1 | Jun 5, 2014 | S | 4,773 | $24.1982 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.08 | Jun 5, 2014 | M | 4,773 | D | — | Jun 15, 2021 | Common Stock | 4,773 | 30,575 | D |
Explanation of responses
- F1The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.17 to $24.31, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- F2This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vests each successive quarter thereafter until fully vested on May 16, 2015.
Remarks
The Form 4 filing made on June 6, 2014 disclosed a sale on June 5, 2014 of 5,000 shares at a price of $24.1982. This Form 4 filing is made to amend the filing as the actual number of shares sold on June 5, 2014 was 4,773 shares at a price of $24.1982.